Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India ETF BSE Sensex | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Category | Equity ETFs | Equity ETFs |
| Plan | Direct | Direct |
| Fund house | Nippon India | Nippon India |
| NAV | ₹966.5151 | ₹29.1863 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 12.2 years | 5.4 years |
| Expense ratio | 0.0% | 0.2% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
Returns
| Nippon India ETF BSE Sensex | Nippon India Nifty Pharma ETF | |
|---|---|---|
| 1 month | +13.68% | +10.82% |
| 3 months | +8.32% | +7.43% |
| 6 months | +12.26% | +14.54% |
| YTD | −0.61% | +25.40% |
| 1 year | −1.10% | +25.57% |
| 3 years (CAGR) | +9.68% | +22.02% |
| 5 years (CAGR) | +8.31% | +16.60% |
| 10 years (CAGR) | +13.60% | — |
| Since launch | +11.23% | +14.02% |
Risk
| Nippon India ETF BSE Sensex | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Volatility | 15.4% | 15.0% |
| Downside volatility | 10.3% | 9.0% |
| Sharpe | 0.21 | 1.04 |
| Sortino | 0.31 | 1.72 |
| Calmar | 0.60 | 1.33 |
| Return / risk | 0.63 | 1.47 |
| Deepest fall | −37.84% | −20.98% |
| Days to recover | 228 | 136 |
| Below its high | −1.24% | −1.75% |
Against benchmark
| Nippon India ETF BSE Sensex | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Alpha | — | +0.00% |
| Beta | — | 1.00 |
| R² | — | 100.0% |
| Up capture | — | 100.0% |
| Down capture | — | 100.0% |
| Tracking error | — | 0.0% |
| Information ratio | — | — |
| Treynor | — | 0.14 |
Consistency
| Nippon India ETF BSE Sensex | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Best 1-year | +94.20% | +65.21% |
| Middle 1-year | +10.77% | +13.46% |
| Worst 1-year | −31.08% | −15.30% |
| 1-year periods with a loss | 18.2% | 25.8% |
| Middle 3-year | +13.68% | +20.51% |
| Positive months | 58.3% | 61.1% |
| Best day | +3.95% | +3.64% |
| Worst day | −5.64% | −4.03% |
| Worst 5% day | −1.29% | −1.62% |
| Positive days | 52.0% | 54.4% |
| NAVs a year | 248 | 248 |
SIP of ₹10,000 a month
| Nippon India ETF BSE Sensex | Nippon India Nifty Pharma ETF | |
|---|---|---|
| 5-year XIRR | +8.70% | +20.60% |
| 5-year value | ₹7,50,503 | ₹10,11,738 |
| 3-year XIRR | +6.26% | +19.58% |
| 1-year XIRR | +12.96% | +34.31% |
Holdings overlap i
| Nippon India ETF BSE Sensex | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Nippon India ETF BSE Sensex | — | 2% |
| Nippon India Nifty Pharma ETF | 2% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | Nippon India ETF BSE Sensex | Nippon India Nifty Pharma ETF |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 2.17% | 18.61% |
Sectors and company size
| Nippon India ETF BSE Sensex | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Large companies | 100.0% | 45.3% |
| Mid companies | — | 47.1% |
| Small companies | — | 7.6% |
| Top 10 holdings | 64.0% | 78.6% |
| Largest sector | Banks 36% | Pharmaceuticals & Biotechnology 100% |